跳至主要内容
临床试验/NCT06989411
NCT06989411已完成不适用

The Effectiveness Of Interferential Current Therapy On Salivary Gland Function In Individuals With Primary Sjogren's Syndrome: Single-Blind Randomized, Controlled Trial

Pamukkale University1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2019年1月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Salivary Flow Rate Measurement

研究概览

简要总结

Purpose:The aim of the study was to investigate the effectiveness of interferential current therapy on salivary gland function in Primary Sjogren's Syndrome (pSS).

Methods:Thirty six pSS were included in the study. Patients were randomly divided into 2 groups (Group 1 (treatment group) n=18; Group II (placebo group) n=18). Salivary flow rate measurement (SFRM), Oral Health-Related Quality of Life-United Kingdom Questionnaire (OHRQOL-UK), Oral Health Impact Profile-14 (OHIP-14), Health Assessment Questionnaire (HAQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI) and Short Form-36 (SF-36) were used for evaluation. All evaluations were done pre-, posttreatment, at 3. month, at 6. month and at 9. month. Clinical pilates exercises and interferential current therapy were applied to Group I while clinical pilates exercises and interferential current therapy as placebo was applied to Group II. All treatments were given three times a week for 8 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

The physiotherapist performing the evaluation was blinded to the groups.

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •To be diagnosed with pSS according to the 2016 European League Against Rheumatism American / College of Rheumatology Classification Criteria,
  • •To be in the 3rd and 4th grade according to the Chisholm-Mason Grading System,
  • •be in the age range of 25-65 years,
  • •To be stable on drug use for at least 3 months or longer, (f) To have agreed to participate in the study.

排除标准

  • •To use antipsychotic, antidepressant, antihypertensive, medical agent for Parkinson's,
  • •Presence of viral infection,
  • •Presence of Diabetes Mellitus,
  • •Receiving head and neck radiotherapy/chemotherapy,
  • •Having a head and neck malignancy,
  • •Having undergone head and neck surgery,
  • •Presence of dehydration,
  • •Pregnancy,
  • •Using cigarettes and alcohol,
  • •Cognitive problems that affect cooperation,
  • •having any other disease that may affect their functions.

研究组 & 干预措施

Group I

Experimental

treatment group

干预措施: Clinical pilates exercises +Interferential current therapy (real current) (Other)

Group II

Placebo Comparator

Control Group

干预措施: Clinical pilates exercises+ Interferential current therapy (Placebo current) (Other)

结局指标

主要结局

Salivary Flow Rate Measurement

时间窗: 15 minutes

Oral Health Impact Profile-14

时间窗: 5 minutes

Total score is between 0 and 56. A high score indicates that the quality of life related to oral and dental health decreases.

Oral Health-Related Quality of Life-United Kingdom Questionnaire

时间窗: 5 minutes

Total scores range from 16 to 80. A high score indicates that the quality of life related to oral and dental health is high.

次要结局

  • Health Assessment Questionnaire(5 minutes)
  • Beck Depression Inventory(7 minutes)
  • Beck Anxiety Inventory(7 minutes)
  • Short Form-36(10 minutes)
  • Pittsburgh Sleep Quality Index(7 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elif Gur Kabul

principal investigator

Uşak University

研究点 (1)

Loading locations...

相似试验